Emmanuel Mas Selected Research

Chylous Ascites

1/2022

Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emmanuel Mas Research Topics

Disease

8	Inflammation (Inflammations) 01/2021 - 11/2009
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2023 - 04/2011
5	Colitis 03/2024 - 04/2011
5	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2013
3	Dysbiosis 03/2024 - 12/2020
3	Pancreatitis 01/2022 - 04/2014
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2022 - 01/2020
3	Alcoholic Fatty Liver 07/2018 - 11/2009
2	Gastroesophageal Reflux (GERD) 01/2023 - 10/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 07/2018
2	Infections 10/2022 - 07/2012
2	Esophagitis 10/2022 - 02/2006
2	Malnutrition (Nutritional Deficiencies) 02/2022 - 01/2019
2	Exocrine Pancreatic Insufficiency 01/2022 - 12/2020
2	Hemorrhage 01/2022 - 01/2021
2	Juvenile polyposis syndrome 01/2021 - 02/2019
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2021 - 01/2021
2	Neoplasms (Cancer) 01/2019 - 12/2017
2	Weight Loss (Weight Reduction) 02/2013 - 11/2009
1	Atherosclerosis 03/2024
1	Colic (Abdominal Cramps) 11/2023
1	Gastroparesis 01/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Pain (Aches) 01/2023
1	Dyspepsia (Indigestion) 01/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Vascular Diseases (Vascular Disease) 01/2023
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2023
1	Hypersensitivity (Allergy) 10/2022
1	Eosinophilic Esophagitis 10/2022
1	Diarrhea 02/2022
1	Edema (Dropsy) 02/2022
1	Steatorrhea 02/2022
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 02/2022
1	Hypoalbuminemia 02/2022
1	Chylothorax 01/2022
1	Chylous Ascites 01/2022
1	Gastritis 01/2022
1	Celiac Disease (Celiac Sprue) 01/2022
1	Eosinophilic enteropathy 01/2022
1	COVID-19 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Disease Progression 01/2021
1	Loeys-Dietz Syndrome 01/2021
1	Carcinogenesis 01/2021
1	Crohn Disease (Crohn's Disease) 01/2020
1	Autoimmune Hepatitis 01/2020

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2011
3	LipidsIBA 02/2022 - 07/2011
3	Triglycerides (Triacylglycerol)IBA 07/2018 - 11/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 01/2023
2	titanium dioxide (Titania)FDA Link 03/2024 - 11/2023
2	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2023
2	SugarsIBA 02/2022 - 07/2018
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 04/2011
2	ivacaftorIBA 01/2021 - 12/2020
2	lumacaftorIBA 01/2021 - 12/2020
2	Capsules (Microcapsules)IBA 01/2019 - 10/2012
2	Glucose (Dextrose)FDA LinkGeneric 02/2013 - 11/2009
2	Methionine (L-Methionine)FDA Link 02/2013 - 11/2009
2	Alanine Transaminase (SGPT)IBA 02/2013 - 11/2009
2	Choline (Choline Chloride)IBA 02/2013 - 11/2009
2	ElafinIBA 10/2012 - 04/2011
1	LDL CholesterolIBA 03/2024
1	oxidized low density lipoproteinIBA 03/2024
1	Dextran SulfateIBA 11/2023
1	CalciumIBA 01/2023
1	Domperidone (Domperidon)IBA 01/2023
1	IonsIBA 02/2022
1	ElectrolytesIBA 02/2022
1	CarbohydratesIBA 02/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Serine Proteases (Serine Protease)IBA 09/2021
1	TrypsinIBA 09/2021
1	AngiotensinsIBA 01/2021
1	EnzymesIBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Pancreatic Elastase (Elastase)IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	MTOR InhibitorsIBA 01/2021
1	TensinsIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	CytokinesIBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Type I Bone Morphogenetic Protein ReceptorsIBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	racecadotril (ecadotril)IBA 01/2020
1	2-mercaptopurineIBA 01/2020
1	SteroidsIBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 02/2019
1	Proteinase-Activated ReceptorsIBA 01/2019

Therapy/Procedure

5	Therapeutics 01/2023 - 10/2020
1	Hypnosis (Mesmerism) 01/2023
1	Colectomy 01/2021
1	Liver Transplantation 01/2021